Search Results for: LJPC
La Jolla Pharmaceutical shares surged after the micro-cap biotech said late Monday that its study for a chronic kidney disease treatment showed a statistically significant improvement.
Published:
From Biohealth Investor Biotechnology LA JOLLA PHARMA [LJPC] +43.10% AURIGA LABORATORIES [ARGA.OB] +19.05% BIONOVO INC [BNVI.OB] +15.76% VION PHARM INC [VION] +12.58% RENOVIS INC [RNVS] +8.07%...
Published:
Weight Watchers, Adient, AxoGen, and La Jolla Pharmaceuticals all posted new 52-week lows Monday.
Published:
Last Updated:
PG&E, La Jolla Pharmaceuticals, AxoGen, and Maxar Technologies all posted new 52-week lows Tuesday.
Published:
Last Updated:
(BTRX) Barrier Therapeutics receives regulatory approval to market Xolegel in Canada for dermatitis.(BWS) Brown Shoe delared 3-2 stock split and raised dividends.(CBRL) CBRL entered 10b5-1 trading...
Published:
The top analyst upgrades, downgrades and other research calls from Monday include American Express, Cisco, First Solar, Goldman Sachs, Nasdaq, Shopify, SunPower and Workday.
Published:
Last Updated:
These five stocks trading under the $10 level have big upside to the analysts' price targets and they are covered with Buy ratings at major Wall Street firms.
Published:
Here are six biotech and pharma stocks that analysts are telling their firm's clients to buy now for solid upside opportunities ahead.
Published:
Last Updated:
One would expect that insiders looking to add to their positions would wait for a downturn in the market. That wasn’t the case this past week.
Published:
There can be some big biotech winners in 2018, given the changing landscape, and any of these 12 could be one.
Published:
Last Updated:
These are the top analyst upgrades, downgrades and initiations from Wall Street analysts on Monday, August 4, 2014. They include Alcatel-Lucent, AEP, Chubb, Chevron, Halcon and Noble.
Published:
La Jolla Pharmaceutical and Sarepta Therapeutics are among seven biotech stocks that have seen some notable insider trading recently.
Published:
Last Updated:
Despite the wild ride the markets have taken, the faith of insiders certainly has not been shaken. It is indeed a positive to see insiders buying shares at current levels.
Published:
Last Updated:
(AAPL) Apple shares traded up 10% after beating earnings hand over fist.(ABI) Applied Bio $0.36 EPS vs $0.35e.(AEP) American Electric Power $0.68 EPS vs $0.71 estimates.(AET) Aetna indicated slightly...
Published:
For really the first time this year, we saw the pace of insider buying jump, and that may signal that while the rally could still have some legs, things are finally calming down some.
Published:
Last Updated: